| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CXCR3 DRD1 DRD2 NPY1R NPY6R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 OR5G3 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P ADGRG1 CCRL2 GPRC6A GPR183 GPR88 S1PR3 OR52N1 BDKRB2 GPR160 TAAR6 NLRP6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 GPRC5D RXFP1 CMKLR1 HCRTR2 | 9.40e-21 | 884 | 126 | 37 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRG1 GABRG3 CXCR3 DRD1 DRD2 NPY1R NPY6R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 OR5G3 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P ADGRG1 CCRL2 GPRC6A GPR183 GPR88 S1PR3 OR52N1 BDKRB2 LEPR GPR160 TAAR6 NLRP6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 ROS1 GPRC5D RXFP1 CMKLR1 HCRTR2 | 5.88e-18 | 1353 | 126 | 41 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.68e-07 | 133 | 126 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.60e-07 | 140 | 126 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 5.77e-06 | 41 | 126 | 5 | GO:0008227 | |
| GeneOntologyMolecularFunction | transporter activity | GABRG1 GABRG3 ABCC3 ANO9 ATP13A4 SLCO6A1 ITPR2 CPTP SEC61A2 ATP2C1 SLCO4C1 SLC41A3 SV2B ATP6V0A4 SCN10A STARD3 KCNN1 LRRC8A SLC13A5 SEC61A1 ABCC10 SLC23A3 | 1.74e-05 | 1289 | 126 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 3.95e-05 | 2 | 126 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | G protein-coupled UDP receptor activity | 3.95e-05 | 2 | 126 | 2 | GO:0045029 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.11e-05 | 100 | 126 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRG1 GABRG3 ABCC3 ANO9 ATP13A4 SLCO6A1 ITPR2 SEC61A2 ATP2C1 SLCO4C1 SLC41A3 SV2B ATP6V0A4 SCN10A KCNN1 LRRC8A SLC13A5 SEC61A1 ABCC10 SLC23A3 | 4.87e-05 | 1180 | 126 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | peptide binding | NPY1R NPY6R GPR22 AVPR1A GPR37L1 NLRP6 SEC61A2 SEC61A1 HCRTR2 | 1.90e-04 | 318 | 126 | 9 | GO:0042277 |
| GeneOntologyMolecularFunction | G protein-coupled pyrimidinergic nucleotide receptor activity | 2.35e-04 | 4 | 126 | 2 | GO:0071553 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG1 GABRG3 ABCC3 ANO9 ATP13A4 ITPR2 ATP2C1 SLC41A3 ATP6V0A4 SCN10A KCNN1 SLC13A5 SEC61A1 ABCC10 | 3.09e-04 | 758 | 126 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | peptide YY receptor activity | 3.90e-04 | 5 | 126 | 2 | GO:0001601 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 3.90e-04 | 5 | 126 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 4.02e-04 | 55 | 126 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | hormone binding | 4.94e-04 | 103 | 126 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 5.74e-04 | 26 | 126 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 5.74e-04 | 26 | 126 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.39e-04 | 109 | 126 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 8.13e-04 | 7 | 126 | 2 | GO:0005000 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 8.13e-04 | 7 | 126 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | dopamine binding | 8.13e-04 | 7 | 126 | 2 | GO:0035240 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.08e-03 | 8 | 126 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | trace-amine receptor activity | 1.08e-03 | 8 | 126 | 2 | GO:0001594 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 1.38e-03 | 9 | 126 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.50e-03 | 36 | 126 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.50e-03 | 36 | 126 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRG1 GABRG3 ANO9 ATP13A4 ITPR2 ATP2C1 SLC41A3 ATP6V0A4 SCN10A KCNN1 LRRC8A SLC13A5 SEC61A1 | 1.52e-03 | 793 | 126 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 1.72e-03 | 10 | 126 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.72e-03 | 10 | 126 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 2.09e-03 | 11 | 126 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.09e-03 | 11 | 126 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.09e-03 | 11 | 126 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | catecholamine binding | 2.94e-03 | 13 | 126 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 2.94e-03 | 13 | 126 | 2 | GO:0045028 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC3 ATP13A4 SLCO6A1 ATP2C1 SLCO4C1 SLC41A3 ATP6V0A4 SLC13A5 ABCC10 | 3.29e-03 | 477 | 126 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | cytokine receptor activity | 3.33e-03 | 97 | 126 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.87e-03 | 50 | 126 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.93e-03 | 15 | 126 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.13e-03 | 103 | 126 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | FMN binding | 4.47e-03 | 16 | 126 | 2 | GO:0010181 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 4.57e-03 | 53 | 126 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.61e-03 | 171 | 126 | 5 | GO:0015103 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CXCR3 DRD1 DRD2 NPY1R NPY6R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 OR5G3 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P ADGRG1 CCRL2 DGKE GPRC6A GPR183 LMBRD2 GPR88 S1PR3 OR52N1 BDKRB2 GPR160 TAAR6 NLRP6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 GPRC5D RXFP1 CMKLR1 HCRTR2 | 1.34e-16 | 1395 | 124 | 39 | GO:0007186 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 9.12e-06 | 286 | 124 | 10 | GO:0007188 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRG1 GABRG3 ABCC3 ANO9 ATP13A4 CXCR3 DRD1 DRD2 HTR2C ITPR2 ATP2C1 SLC41A3 P2RY6 ATP6V0A4 SCN10A KCNN1 LRRC8A SLC13A5 SEC61A1 ABCC10 | 1.08e-05 | 1115 | 124 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C ITPR2 ATP2C1 P2RY6 SV2B HCRTR2 | 1.12e-05 | 359 | 124 | 11 | GO:0006874 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C AVPR1A ITPR2 ATP2C1 P2RY6 SV2B ATP6V0A4 TMPRSS3 HCRTR2 | 1.88e-05 | 611 | 124 | 14 | GO:0030003 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRG1 GABRG3 ABCC3 ANO9 ATP13A4 CXCR3 DRD1 DRD2 HTR2C HTR7 ITPR2 ATP2C1 SLCO4C1 SLC41A3 P2RY6 ATP6V0A4 SCN10A KCNN1 LRRC8A SLC13A5 SEC61A1 ABCC10 | 2.18e-05 | 1374 | 124 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C AVPR1A ITPR2 ATP2C1 P2RY6 SV2B ATP6V0A4 TMPRSS3 HCRTR2 | 2.29e-05 | 622 | 124 | 14 | GO:0006873 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C ITPR2 ATP2C1 P2RY6 SV2B HCRTR2 | 2.35e-05 | 389 | 124 | 11 | GO:0055074 |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 2.80e-05 | 98 | 124 | 6 | GO:0019229 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 3.02e-05 | 30 | 124 | 4 | GO:0014821 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRG1 GABRG3 ANO9 ATP13A4 CXCR3 DRD1 DRD2 HTR2C ITPR2 ATP2C1 SLC41A3 P2RY6 ATP6V0A4 SCN10A KCNN1 LRRC8A SLC13A5 SEC61A1 | 3.72e-05 | 1017 | 124 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 5.64e-05 | 35 | 124 | 4 | GO:0071875 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C AVPR1A LEPR ITPR2 ATP2C1 P2RY6 SV2B ATP6V0A4 TMPRSS3 LRRC8A HCRTR2 | 6.34e-05 | 866 | 124 | 16 | GO:0055082 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C AVPR1A ITPR2 ATP2C1 P2RY6 SV2B ATP6V0A4 TMPRSS3 HCRTR2 | 8.84e-05 | 705 | 124 | 14 | GO:0055080 |
| GeneOntologyBiologicalProcess | vasoconstriction | 9.14e-05 | 121 | 124 | 6 | GO:0042310 | |
| GeneOntologyBiologicalProcess | peristalsis | 9.15e-05 | 15 | 124 | 3 | GO:0030432 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C AVPR1A ITPR2 ATP2C1 P2RY6 SV2B ATP6V0A4 TMPRSS3 HCRTR2 | 1.06e-04 | 717 | 124 | 14 | GO:0050801 |
| GeneOntologyBiologicalProcess | negative regulation of circadian rhythm | 1.12e-04 | 16 | 124 | 3 | GO:0042754 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.21e-04 | 183 | 124 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.54e-04 | 133 | 124 | 6 | GO:0007200 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.58e-04 | 191 | 124 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.09e-04 | 266 | 124 | 8 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 2.11e-04 | 141 | 124 | 6 | GO:0051588 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 2.55e-04 | 146 | 124 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 2.65e-04 | 147 | 124 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C AVPR1A LEPR ITPR2 ATP2C1 P2RY6 SV2B ATP6V0A4 TMPRSS3 LRRC8A HCRTR2 | 2.65e-04 | 981 | 124 | 16 | GO:0019725 |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC3 DRD2 HTR2C AVPR1A SLCO6A1 BDKRB2 CPTP SLCO4C1 LRRC8A SLC13A5 ABCC10 | 2.82e-04 | 515 | 124 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 2.85e-04 | 149 | 124 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 3.28e-04 | 153 | 124 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 3.28e-04 | 153 | 124 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | sensitization | 3.54e-04 | 5 | 124 | 2 | GO:0046960 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | ATP13A4 CXCR3 DRD1 DRD2 NPY1R HTR2C ITPR2 ATP2C1 P2RY6 SV2B TMPRSS3 HCRTR2 | 3.75e-04 | 622 | 124 | 12 | GO:0098771 |
| GeneOntologyBiologicalProcess | grooming behavior | 3.91e-04 | 24 | 124 | 3 | GO:0007625 | |
| GeneOntologyBiologicalProcess | feeding behavior | 4.45e-04 | 162 | 124 | 6 | GO:0007631 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRG1 GABRG3 PLK2 DRD1 DRD2 NPY1R HTR2C HTR7 DGKE SV2B KCNN1 TMEM108 PRRT1 MCTP2 HCRTR2 | 4.74e-04 | 931 | 124 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRG1 GABRG3 PLK2 DRD1 DRD2 NPY1R HTR2C HTR7 DGKE SV2B KCNN1 TMEM108 PRRT1 MCTP2 HCRTR2 | 4.74e-04 | 931 | 124 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 4.98e-04 | 61 | 124 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRG1 GABRG3 PLK2 DRD1 DRD2 NPY1R HTR2C HTR7 DGKE SV2B KCNN1 TMEM108 PRRT1 MCTP2 HCRTR2 | 5.18e-04 | 939 | 124 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | negative regulation of circadian sleep/wake cycle, sleep | 5.29e-04 | 6 | 124 | 2 | GO:0042321 | |
| GeneOntologyBiologicalProcess | cerebral cortex GABAergic interneuron migration | 5.29e-04 | 6 | 124 | 2 | GO:0021853 | |
| GeneOntologyBiologicalProcess | wybutosine metabolic process | 5.29e-04 | 6 | 124 | 2 | GO:0031590 | |
| GeneOntologyBiologicalProcess | wybutosine biosynthetic process | 5.29e-04 | 6 | 124 | 2 | GO:0031591 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 5.98e-04 | 64 | 124 | 4 | GO:1903351 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 6.13e-04 | 392 | 124 | 9 | GO:0070588 | |
| GeneOntologyBiologicalProcess | response to dopamine | 6.72e-04 | 66 | 124 | 4 | GO:1903350 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 7.38e-04 | 7 | 124 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 7.53e-04 | 68 | 124 | 4 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 7.53e-04 | 68 | 124 | 4 | GO:0071870 | |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRG1 GABRG3 PLK2 DRD1 DRD2 NPY1R HTR2C HTR7 DGKE SV2B KCNN1 TMEM108 PRRT1 MCTP2 HCRTR2 | 7.71e-04 | 976 | 124 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 7.75e-04 | 180 | 124 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 8.05e-04 | 326 | 124 | 8 | GO:1903522 | |
| GeneOntologyBiologicalProcess | dentate gyrus development | 8.43e-04 | 31 | 124 | 3 | GO:0021542 | |
| GeneOntologyBiologicalProcess | circadian behavior | 8.86e-04 | 71 | 124 | 4 | GO:0048512 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 9.80e-04 | 8 | 124 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to membrane, translocation | 9.80e-04 | 8 | 124 | 2 | GO:0031204 | |
| GeneOntologyBiologicalProcess | cerebral cortex GABAergic interneuron development | 9.80e-04 | 8 | 124 | 2 | GO:0021894 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 9.83e-04 | 73 | 124 | 4 | GO:0071715 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 9.83e-04 | 73 | 124 | 4 | GO:0071869 | |
| GeneOntologyBiologicalProcess | rhythmic behavior | 1.03e-03 | 74 | 124 | 4 | GO:0007622 | |
| GeneOntologyBiologicalProcess | response to monoamine | 1.03e-03 | 74 | 124 | 4 | GO:0071867 | |
| GeneOntologyBiologicalProcess | cognition | 1.05e-03 | 423 | 124 | 9 | GO:0050890 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.06e-03 | 128 | 124 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 1.14e-03 | 344 | 124 | 8 | GO:0003018 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle | 1.21e-03 | 35 | 124 | 3 | GO:0042749 | |
| GeneOntologyBiologicalProcess | interneuron migration from the subpallium to the cortex | 1.26e-03 | 9 | 124 | 2 | GO:0021830 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 1.26e-03 | 9 | 124 | 2 | GO:0060158 | |
| GeneOntologyBiologicalProcess | regulation of dopamine uptake involved in synaptic transmission | 1.26e-03 | 9 | 124 | 2 | GO:0051584 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine uptake involved in synaptic transmission | 1.26e-03 | 9 | 124 | 2 | GO:0051940 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.26e-03 | 133 | 124 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP13A4 CXCR3 DRD1 DRD2 HTR2C ITPR2 ATP2C1 SLC41A3 P2RY6 ATP6V0A4 SCN10A KCNN1 SLC13A5 SEC61A1 | 1.30e-03 | 922 | 124 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle process | 1.31e-03 | 36 | 124 | 3 | GO:0022410 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.38e-03 | 80 | 124 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 1.40e-03 | 202 | 124 | 6 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 1.40e-03 | 202 | 124 | 6 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 1.44e-03 | 203 | 124 | 6 | GO:0035150 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP13A4 CXCR3 DRD1 DRD2 HTR2C ITPR2 ATP2C1 SLC41A3 P2RY6 ATP6V0A4 SCN10A KCNN1 SLC13A5 SEC61A1 | 1.59e-03 | 942 | 124 | 14 | GO:0098655 |
| GeneOntologyCellularComponent | receptor complex | GABRG1 GABRG3 DRD1 DRD2 HTR2C GPR37L1 CUBN ITGB7 LEPR GPR160 ITPR2 ROS1 GPRC5D | 4.23e-05 | 581 | 124 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ATP13A4 DRD2 LITAFD SCAMP3 DCSTAMP CUBN ITPR2 CPTP TYRP1 TM9SF2 SLCO4C1 SV2B ATP6V0A4 STARD3 TMEM108 PRRT1 SEC61A1 MCTP2 VPS13B | 2.50e-04 | 1307 | 124 | 19 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ATP13A4 DRD2 LITAFD SCAMP3 DCSTAMP CUBN ITPR2 CPTP TYRP1 TM9SF2 SLCO4C1 SV2B ATP6V0A4 STARD3 TMEM108 PRRT1 SEC61A1 MCTP2 VPS13B | 2.98e-04 | 1325 | 124 | 19 | GO:0012506 |
| GeneOntologyCellularComponent | Sec61 translocon complex | 3.45e-04 | 5 | 124 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | translocon complex | 5.15e-04 | 6 | 124 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 6.54e-04 | 320 | 124 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | endosome membrane | ATP13A4 LITAFD SCAMP3 DCSTAMP CPTP TYRP1 TM9SF2 ATP6V0A4 STARD3 TMEM108 VPS13B | 9.24e-04 | 602 | 124 | 11 | GO:0010008 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.25e-03 | 354 | 124 | 8 | GO:0009925 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | GABRG1 ABCC3 MMS22L DRD1 DRD2 NPY1R COL12A1 WWOX HTR2C HTR7 SMC6 ELOVL5 GPR152 ADGRG1 LEPR CLDN9 SEC61A2 SLC41A3 TYW1B ATP6V0A4 LTN1 SCN10A TMEM108 TYW1 VPS13B | 2.83e-05 | 1486 | 99 | 25 | MP:0002067 |
| MousePheno | abnormal circulating corticosterone level | 3.67e-05 | 88 | 99 | 6 | MP:0005345 | |
| MousePheno | abnormal circulating glucocorticoid level | 4.44e-05 | 91 | 99 | 6 | MP:0003366 | |
| MousePheno | abnormal corticosterone level | 5.33e-05 | 94 | 99 | 6 | MP:0003963 | |
| Domain | G_PROTEIN_RECEP_F1_1 | CXCR3 DRD1 DRD2 NPY1R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P CCRL2 GPR183 GPR88 S1PR3 OR52N1 BDKRB2 GPR160 TAAR6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 RXFP1 CMKLR1 HCRTR2 | 2.81e-18 | 685 | 119 | 31 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | CXCR3 DRD1 DRD2 NPY1R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P CCRL2 GPR183 GPR88 S1PR3 OR52N1 BDKRB2 GPR160 TAAR6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 RXFP1 CMKLR1 HCRTR2 | 3.60e-18 | 691 | 119 | 31 | PS50262 |
| Domain | GPCR_Rhodpsn | CXCR3 DRD1 DRD2 NPY1R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P CCRL2 GPR183 GPR88 S1PR3 OR52N1 BDKRB2 GPR160 TAAR6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 RXFP1 CMKLR1 HCRTR2 | 3.75e-18 | 692 | 119 | 31 | IPR000276 |
| Domain | 7tm_1 | CXCR3 DRD1 DRD2 NPY1R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 AVPR1A GPR152 GPR37L1 OR1F12P TAAR3P CCRL2 GPR183 GPR88 S1PR3 OR52N1 BDKRB2 TAAR6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 RXFP1 CMKLR1 HCRTR2 | 1.95e-17 | 677 | 119 | 30 | PF00001 |
| Domain | GPCR_Rhodpsn_7TM | CXCR3 DRD1 DRD2 NPY1R OR4K2 GPR22 HTR2C MAS1L GPR50 HTR7 AVPR1A GPR152 GPR37L1 CCRL2 GPR183 GPR88 S1PR3 OR52N1 BDKRB2 GPR160 TAAR6 OR6F1 OR52B4 P2RY6 OR52N5 P2RY14 RXFP1 CMKLR1 HCRTR2 | 1.37e-16 | 670 | 119 | 29 | IPR017452 |
| Domain | 7TM_GPCR_Srsx | 4.04e-08 | 112 | 119 | 9 | SM01381 | |
| Domain | Plug_translocon | 4.03e-05 | 2 | 119 | 2 | PF10559 | |
| Domain | SecY_su_dom | 4.03e-05 | 2 | 119 | 2 | IPR023201 | |
| Domain | SecY | 4.03e-05 | 2 | 119 | 2 | PF00344 | |
| Domain | tRNA_wybutosine-synth | 4.03e-05 | 2 | 119 | 2 | IPR013917 | |
| Domain | SECY_1 | 4.03e-05 | 2 | 119 | 2 | PS00755 | |
| Domain | SECY_2 | 4.03e-05 | 2 | 119 | 2 | PS00756 | |
| Domain | - | 4.03e-05 | 2 | 119 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 4.03e-05 | 2 | 119 | 2 | IPR019561 | |
| Domain | SecY_CS | 4.03e-05 | 2 | 119 | 2 | IPR030659 | |
| Domain | Wyosine_form | 4.03e-05 | 2 | 119 | 2 | PF08608 | |
| Domain | SecY/SEC61-alpha | 4.03e-05 | 2 | 119 | 2 | IPR002208 | |
| Domain | Cul7 | 1.20e-04 | 3 | 119 | 2 | PF11515 | |
| Domain | GABBAg_rcpt | 1.20e-04 | 3 | 119 | 2 | IPR005437 | |
| Domain | CPH_domain | 1.20e-04 | 3 | 119 | 2 | IPR021097 | |
| Domain | Dopamine_rcpt | 3.98e-04 | 5 | 119 | 2 | IPR000929 | |
| Domain | TAAR_fam | 8.28e-04 | 7 | 119 | 2 | IPR009132 | |
| Domain | APC_su10/DOC_dom | 8.28e-04 | 7 | 119 | 2 | IPR004939 | |
| Domain | DOC | 8.28e-04 | 7 | 119 | 2 | PS51284 | |
| Domain | SRCR_2 | 8.28e-04 | 7 | 119 | 2 | PF15494 | |
| Domain | APC10 | 8.28e-04 | 7 | 119 | 2 | SM01337 | |
| Domain | ANAPC10 | 8.28e-04 | 7 | 119 | 2 | PF03256 | |
| Domain | Cullin_Nedd8 | 1.10e-03 | 8 | 119 | 2 | PF10557 | |
| Domain | FLAVODOXIN_LIKE | 1.10e-03 | 8 | 119 | 2 | PS50902 | |
| Domain | Cullin_Nedd8 | 1.10e-03 | 8 | 119 | 2 | SM00884 | |
| Domain | Flavodoxin/NO_synth | 1.10e-03 | 8 | 119 | 2 | IPR008254 | |
| Domain | Cullin_neddylation_domain | 1.10e-03 | 8 | 119 | 2 | IPR019559 | |
| Domain | Flavdoxin-like | 1.10e-03 | 8 | 119 | 2 | IPR001094 | |
| Domain | Flavodoxin_1 | 1.10e-03 | 8 | 119 | 2 | PF00258 | |
| Domain | rSAM | 1.41e-03 | 9 | 119 | 2 | IPR007197 | |
| Domain | Radical_SAM | 1.41e-03 | 9 | 119 | 2 | PF04055 | |
| Domain | Cullin_homology | 1.41e-03 | 9 | 119 | 2 | IPR016158 | |
| Domain | Flavoprotein-like_dom | 1.75e-03 | 10 | 119 | 2 | IPR029039 | |
| Domain | Cullin | 1.75e-03 | 10 | 119 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.75e-03 | 10 | 119 | 2 | PS50069 | |
| Domain | Cullin_N | 1.75e-03 | 10 | 119 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 1.75e-03 | 10 | 119 | 2 | PS01256 | |
| Domain | - | 1.75e-03 | 10 | 119 | 2 | 3.40.50.360 | |
| Domain | LDLR_class-A_CS | 2.10e-03 | 40 | 119 | 3 | IPR023415 | |
| Domain | MRGPCRFAMILY | 2.13e-03 | 11 | 119 | 2 | IPR026234 | |
| Domain | OA_transporter | 2.55e-03 | 12 | 119 | 2 | IPR004156 | |
| Domain | OATP | 2.55e-03 | 12 | 119 | 2 | PF03137 | |
| Domain | Ldl_recept_a | 2.94e-03 | 45 | 119 | 3 | PF00057 | |
| Domain | - | 3.14e-03 | 46 | 119 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.54e-03 | 48 | 119 | 3 | PS01209 | |
| Domain | CUB | 3.75e-03 | 49 | 119 | 3 | PF00431 | |
| Domain | LDLRA_2 | 3.75e-03 | 49 | 119 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.75e-03 | 49 | 119 | 3 | IPR002172 | |
| Domain | LDLa | 3.75e-03 | 49 | 119 | 3 | SM00192 | |
| Domain | CUB | 3.97e-03 | 50 | 119 | 3 | SM00042 | |
| Domain | Chemokine_rcpt | 4.56e-03 | 16 | 119 | 2 | IPR000355 | |
| Domain | MAM_1 | 4.56e-03 | 16 | 119 | 2 | PS00740 | |
| Domain | CUB | 4.69e-03 | 53 | 119 | 3 | PS01180 | |
| Domain | MAM | 5.14e-03 | 17 | 119 | 2 | SM00137 | |
| Domain | CUB_dom | 5.75e-03 | 57 | 119 | 3 | IPR000859 | |
| Domain | MAM | 5.76e-03 | 18 | 119 | 2 | PF00629 | |
| Domain | Rib_L2_dom2 | 5.76e-03 | 18 | 119 | 2 | IPR014722 | |
| Domain | Cation_ATPase_N | 5.76e-03 | 18 | 119 | 2 | PF00690 | |
| Domain | - | 5.76e-03 | 18 | 119 | 2 | 2.30.30.30 | |
| Domain | MAM_dom | 5.76e-03 | 18 | 119 | 2 | IPR000998 | |
| Domain | Cation_ATPase_N | 5.76e-03 | 18 | 119 | 2 | SM00831 | |
| Domain | MAM_2 | 5.76e-03 | 18 | 119 | 2 | PS50060 | |
| Pathway | WP_GPCRS_NONODORANT | CXCR3 DRD1 DRD2 NPY1R NPY6R HTR2C GPR50 HTR7 AVPR1A ADGRG1 CCRL2 GPRC6A S1PR3 BDKRB2 P2RY6 P2RY14 GPRC5D RXFP1 HCRTR2 | 9.28e-15 | 266 | 94 | 19 | MM15843 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | CXCR3 DRD1 DRD2 NPY1R NPY6R GPR22 HTR2C MAS1L GPR50 HTR7 AVPR1A GPR37L1 CCRL2 BDKRB2 P2RY6 P2RY14 CMKLR1 HCRTR2 | 8.72e-14 | 260 | 94 | 18 | M39397 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CXCR3 DRD1 DRD2 NPY1R HTR2C HTR7 AVPR1A GPR37L1 TAAR3P CCRL2 GPR183 S1PR3 BDKRB2 TAAR6 P2RY6 P2RY14 RXFP1 CMKLR1 HCRTR2 | 5.37e-13 | 333 | 94 | 19 | MM14963 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRG1 GABRG3 DRD1 DRD2 NPY1R HTR2C GPR50 HTR7 AVPR1A S1PR3 BDKRB2 LEPR TAAR6 P2RY6 P2RY14 RXFP1 HCRTR2 | 2.41e-12 | 272 | 94 | 17 | M13380 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CXCR3 DRD1 DRD2 NPY1R HTR2C HTR7 AVPR1A GPR37L1 CCRL2 GPR183 S1PR3 BDKRB2 TAAR6 P2RY6 P2RY14 RXFP1 CMKLR1 HCRTR2 | 5.04e-12 | 330 | 94 | 18 | M18334 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CXCR3 DRD1 DRD2 NPY1R HTR2C HTR7 AVPR1A GPR37L1 TAAR3P CCRL2 GPRC6A GPR183 S1PR3 BDKRB2 TAAR6 P2RY6 P2RY14 RXFP1 CMKLR1 HCRTR2 | 5.30e-12 | 430 | 94 | 20 | MM15160 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CXCR3 DRD1 DRD2 NPY1R HTR2C HTR7 AVPR1A GPR37L1 CCRL2 GPRC6A GPR183 S1PR3 BDKRB2 TAAR6 P2RY6 P2RY14 RXFP1 CMKLR1 HCRTR2 | 1.67e-10 | 463 | 94 | 19 | M507 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CXCR3 DRD1 DRD2 NPY1R HTR2C HTR7 AVPR1A GPR37L1 TAAR3P CCRL2 DGKE GPRC6A GPR183 S1PR3 BDKRB2 TAAR6 ITPR2 P2RY6 P2RY14 RXFP1 CMKLR1 HCRTR2 | 1.73e-10 | 646 | 94 | 22 | MM14962 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | CXCR3 NPY1R NPY6R HTR2C GPR50 HTR7 AVPR1A GPR37L1 CCRL2 BDKRB2 P2RY6 P2RY14 CMKLR1 | 2.86e-10 | 186 | 94 | 13 | MM15994 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CXCR3 DRD1 DRD2 NPY1R HTR2C HTR7 AVPR1A GPR37L1 CCRL2 DGKE GPRC6A GPR183 S1PR3 BDKRB2 TAAR6 ITPR2 P2RY6 P2RY14 RXFP1 CMKLR1 HCRTR2 | 4.99e-09 | 702 | 94 | 21 | M746 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.23e-07 | 42 | 94 | 6 | MM14971 | |
| Pathway | WP_GPCRS_ODORANT | GPR22 GPR152 GPR37L1 TAAR3P GPR183 GPR88 GPR160 TAAR6 CMKLR1 | 9.94e-07 | 157 | 94 | 9 | MM15872 |
| Pathway | WP_GPCRS_OTHER | 2.78e-06 | 93 | 94 | 7 | M39629 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 8.29e-06 | 42 | 94 | 5 | M5868 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.04e-05 | 75 | 94 | 6 | M39696 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 5.03e-05 | 197 | 94 | 8 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 5.03e-05 | 197 | 94 | 8 | MM14970 | |
| Pathway | WP_MONOAMINE_GPCRS | 5.08e-05 | 31 | 94 | 4 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.54e-05 | 33 | 94 | 4 | M39585 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 7.88e-05 | 210 | 94 | 8 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.91e-05 | 217 | 94 | 8 | M18437 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.02e-04 | 70 | 94 | 5 | MM15959 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 3.38e-04 | 50 | 94 | 4 | M47951 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 4.34e-04 | 5 | 94 | 2 | M27301 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 4.34e-04 | 5 | 94 | 2 | MM15007 | |
| Pathway | WP_GPCRS_OTHER | 4.49e-04 | 96 | 94 | 5 | MM15939 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.17e-03 | 314 | 94 | 8 | M600 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.21e-03 | 178 | 94 | 6 | M2890 | |
| Pubmed | CXCR3 DRD1 DRD2 HTR2C HTR7 AVPR1A TAAR3P BDKRB2 TAAR6 P2RY6 P2RY14 | 1.97e-10 | 200 | 126 | 11 | 18240029 | |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 1.37e-09 | 182 | 126 | 10 | 20468064 | |
| Pubmed | GABRG1 GABRG3 DRD1 DRD2 HTR2C HTR7 AVPR1A BDKRB2 LEPR HCRTR2 | 1.57e-07 | 300 | 126 | 10 | 19086053 | |
| Pubmed | Analysis of SNP profiles in patients with major depressive disorder. | 1.85e-07 | 4 | 126 | 3 | 15927089 | |
| Pubmed | 3.29e-07 | 75 | 126 | 6 | 2834384 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 4.49e-07 | 79 | 126 | 6 | 12679517 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 4.55e-07 | 128 | 126 | 7 | 19058789 | |
| Pubmed | Functional activity of serotoninergic and melatoninergic systems expressed in the skin. | 9.21e-07 | 6 | 126 | 3 | 12767050 | |
| Pubmed | 1.61e-06 | 7 | 126 | 3 | 20071033 | ||
| Pubmed | 7.50e-06 | 11 | 126 | 3 | 18855532 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 8.29e-06 | 130 | 126 | 6 | 19874574 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | DGKE DHRS1 ITPR2 ATP2C1 NDC1 TMTC3 SLC41A3 LPCAT2 LRRC8A TYW1 | 8.48e-06 | 468 | 126 | 10 | 31056421 |
| Pubmed | Polymorphisms in dopaminergic genes predict proactive processes of response inhibition. | 1.30e-05 | 2 | 126 | 2 | 30586202 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 11567069 | ||
| Pubmed | When chocolate seeking becomes compulsion: gene-environment interplay. | 1.30e-05 | 2 | 126 | 2 | 25781028 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22100647 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20081237 | ||
| Pubmed | Distinct functions of the two isoforms of dopamine D2 receptors. | 1.30e-05 | 2 | 126 | 2 | 11089973 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 33380525 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18030347 | ||
| Pubmed | D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms. | 1.30e-05 | 2 | 126 | 2 | 23680635 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 27021648 | ||
| Pubmed | Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humans. | 1.30e-05 | 2 | 126 | 2 | 11920160 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 35172858 | ||
| Pubmed | Aluminum exposure decreases dopamine D1 and D2 receptor expression in mouse brain. | 1.30e-05 | 2 | 126 | 2 | 17984145 | |
| Pubmed | Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking. | 1.30e-05 | 2 | 126 | 2 | 30622165 | |
| Pubmed | Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice. | 1.30e-05 | 2 | 126 | 2 | 11423089 | |
| Pubmed | Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. | 1.30e-05 | 2 | 126 | 2 | 18716204 | |
| Pubmed | In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward. | 1.30e-05 | 2 | 126 | 2 | 26831103 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19012810 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 27472173 | ||
| Pubmed | Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity. | 1.30e-05 | 2 | 126 | 2 | 25161883 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 30258218 | ||
| Pubmed | Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase. | 1.30e-05 | 2 | 126 | 2 | 18984584 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25076876 | ||
| Pubmed | Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice. | 1.30e-05 | 2 | 126 | 2 | 15272078 | |
| Pubmed | The role of dopamine receptors in regulating the size of axonal arbors. | 1.30e-05 | 2 | 126 | 2 | 11438590 | |
| Pubmed | Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells. | 1.30e-05 | 2 | 126 | 2 | 11918350 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19274089 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25556545 | ||
| Pubmed | Dopamine receptor activation increases HIV entry into primary human macrophages. | 1.30e-05 | 2 | 126 | 2 | 25268786 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23231809 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29847669 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20805489 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24719111 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10051231 | ||
| Pubmed | Role of dopamine D2 receptors in optimizing choice strategy in a dynamic and uncertain environment. | 1.30e-05 | 2 | 126 | 2 | 25389395 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17455212 | ||
| Pubmed | Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. | 1.30e-05 | 2 | 126 | 2 | 11069937 | |
| Pubmed | Lack of dopaminergic inputs elongates the primary cilia of striatal neurons. | 1.30e-05 | 2 | 126 | 2 | 24830745 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26442961 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23349838 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19228458 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 36464669 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18480044 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 14960355 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8294904 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9988094 | ||
| Pubmed | Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver. | 1.30e-05 | 2 | 126 | 2 | 20578149 | |
| Pubmed | Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. | 1.30e-05 | 2 | 126 | 2 | 15942051 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 32833186 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21303698 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12417685 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8001143 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16162496 | ||
| Pubmed | Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. | 1.30e-05 | 2 | 126 | 2 | 17324452 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 36727569 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24078558 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24322206 | ||
| Pubmed | Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor. | 1.30e-05 | 2 | 126 | 2 | 28119185 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19117916 | ||
| Pubmed | A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease. | 1.30e-05 | 2 | 126 | 2 | 25437209 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16846218 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28473642 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28860974 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17409246 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18363855 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20592018 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29183706 | ||
| Pubmed | Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice. | 1.30e-05 | 2 | 126 | 2 | 17712281 | |
| Pubmed | Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles. | 1.30e-05 | 2 | 126 | 2 | 11783439 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29603470 | ||
| Pubmed | Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function. | 1.30e-05 | 2 | 126 | 2 | 21196914 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19143836 | ||
| Pubmed | Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward. | 1.30e-05 | 2 | 126 | 2 | 34264865 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23843993 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 31123756 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28128287 | ||
| Pubmed | Dopamine receptors D1 and D2 are related to observed maternal behavior. | 1.30e-05 | 2 | 126 | 2 | 22574669 | |
| Pubmed | Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. | 1.30e-05 | 2 | 126 | 2 | 15159403 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25729269 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22884478 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22764221 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19005068 | ||
| Pubmed | Bradykinin B2 and dopamine D2 receptors form a functional dimer. | 1.30e-05 | 2 | 126 | 2 | 28757212 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19182156 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18279319 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 39438478 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19520364 | ||
| Pubmed | Hyperthermic and lethal effects of methamphetamine: roles of dopamine D1 and D2 receptors. | 1.30e-05 | 2 | 126 | 2 | 18486343 | |
| Interaction | CRELD1 interactions | 4.65e-07 | 163 | 117 | 9 | int:CRELD1 | |
| Interaction | TTYH1 interactions | CDS1 DRD2 WWOX GPR50 DGKE LMBRD2 NDC1 TMTC3 STARD3 LRRC8A ABCC10 | 1.42e-06 | 300 | 117 | 11 | int:TTYH1 |
| Interaction | GPR182 interactions | KNTC1 CDS1 MMS22L ELOVL5 ADGRG1 SCAMP3 LMBRD2 SEC61A2 ATP2C1 LPCAT2 LTN1 TYW1 GCN1 | 2.45e-06 | 455 | 117 | 13 | int:GPR182 |
| Interaction | HTR2C interactions | 1.09e-05 | 130 | 117 | 7 | int:HTR2C | |
| Interaction | ARLN interactions | 1.50e-05 | 91 | 117 | 6 | int:ARLN | |
| Interaction | GPR12 interactions | 1.70e-05 | 93 | 117 | 6 | int:GPR12 | |
| Interaction | LPAR1 interactions | 3.14e-05 | 210 | 117 | 8 | int:LPAR1 | |
| Interaction | UNC93B1 interactions | GPR37L1 DGKE SCAMP3 LMBRD2 ITPR2 NDC1 TM9SF2 LTN1 GPRC5D CMKLR1 GCN1 | 3.17e-05 | 417 | 117 | 11 | int:UNC93B1 |
| Interaction | TMEM9 interactions | 5.28e-05 | 226 | 117 | 8 | int:TMEM9 | |
| Interaction | PCDHGC4 interactions | 6.63e-05 | 73 | 117 | 5 | int:PCDHGC4 | |
| Interaction | SCAP interactions | 7.51e-05 | 121 | 117 | 6 | int:SCAP | |
| Interaction | PLD3 interactions | 9.55e-05 | 246 | 117 | 8 | int:PLD3 | |
| Interaction | LRRC25 interactions | 1.04e-04 | 185 | 117 | 7 | int:LRRC25 | |
| Interaction | IGFBP5 interactions | 1.07e-04 | 129 | 117 | 6 | int:IGFBP5 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.43e-09 | 78 | 89 | 8 | 262 | |
| GeneFamily | Dopamine receptors | 2.37e-04 | 5 | 89 | 2 | 181 | |
| GeneFamily | Cullins | 6.58e-04 | 8 | 89 | 2 | 1032 | |
| GeneFamily | Trace amine receptors | 8.43e-04 | 9 | 89 | 2 | 188 | |
| GeneFamily | Purinergic receptors P2Y | 1.05e-03 | 10 | 89 | 2 | 213 | |
| GeneFamily | Neuropeptide receptors | 1.05e-03 | 10 | 89 | 2 | 854 | |
| GeneFamily | Olfactory receptors, family 52 | 1.80e-03 | 49 | 89 | 3 | 165 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 1.80e-03 | 13 | 89 | 2 | 170 | |
| GeneFamily | ATP binding cassette subfamily C | 1.80e-03 | 13 | 89 | 2 | 807 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.88e-03 | 19 | 89 | 2 | 563 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 6.26e-03 | 76 | 89 | 3 | 743 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-06 | 197 | 126 | 7 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-06 | 197 | 126 | 7 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-06 | 200 | 126 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-06 | 156 | 126 | 6 | 39aa3adbee9f04cdc0055487d393edfa515e062b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-06 | 156 | 126 | 6 | a09e3aefe78d63ad5428ad48c6f83e547eb819f6 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.15e-06 | 159 | 126 | 6 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-06 | 161 | 126 | 6 | 1011094c54381d52566e24c92f89f2efc2aa3eea | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.34e-06 | 164 | 126 | 6 | ea02ca343b2b28e437304de889e2ae1e315a1197 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.60e-06 | 165 | 126 | 6 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.02e-06 | 170 | 126 | 6 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.32e-06 | 171 | 126 | 6 | bf475a69db04d4a886e442704955c6a96ff0de46 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-06 | 171 | 126 | 6 | b327fb7813a3cdae06c8a4f8a0c256e9a20132f6 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.96e-06 | 173 | 126 | 6 | a361474ad6f058bb3d3f9671bae697205535090b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 174 | 126 | 6 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-05 | 176 | 126 | 6 | fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-05 | 103 | 126 | 5 | d8965b338b90ddc0686ea0d94e9a330128566c39 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 177 | 126 | 6 | 64fbf799e7b0c4003b2f486cc41b0f7e7c11ea0c | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 177 | 126 | 6 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 178 | 126 | 6 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 179 | 126 | 6 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-05 | 180 | 126 | 6 | 3d9f3e6f13e558279b4ef43e2c44c7c50d761745 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 181 | 126 | 6 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 1.29e-05 | 181 | 126 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 181 | 126 | 6 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 181 | 126 | 6 | b9fe3833a6a56b9fbe5c257393fdbea5bf8ac4a3 | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 1.29e-05 | 181 | 126 | 6 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 1.29e-05 | 181 | 126 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 182 | 126 | 6 | ad5c99ec62cdab347d3a03c971d981e3b924020c | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 183 | 126 | 6 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 184 | 126 | 6 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-05 | 185 | 126 | 6 | ed7b26bdebfd0df2b4f5020a855a052d94ae7219 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.50e-05 | 186 | 126 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-05 | 187 | 126 | 6 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-05 | 187 | 126 | 6 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-05 | 188 | 126 | 6 | c1b8682f2edb45d51bf91ebf429dff1cb57a7a73 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-05 | 188 | 126 | 6 | 6b0e0192519ea3ca49fb21de3da9a0a108fcb64d | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-05 | 188 | 126 | 6 | 0b19c35fdc2b9e064e8f03ef69ae08644794ec24 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 190 | 126 | 6 | 1687e133a88c3d036a33a4f8aeefe320a4f02c39 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 190 | 126 | 6 | 3cfc2646ba25b4bd8bb443cc1f46e18a270a1969 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 190 | 126 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 190 | 126 | 6 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-05 | 190 | 126 | 6 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.75e-05 | 191 | 126 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Control-Myeloid-tDC|Control / Disease, Lineage and Cell Type | 1.75e-05 | 191 | 126 | 6 | 5c1d6a52181eba01e9177d00fe941dda85ef7eb2 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-05 | 191 | 126 | 6 | faf4de97003a938a243b0101456913c2b0e1804f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 192 | 126 | 6 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-05 | 192 | 126 | 6 | 3674c81aeee6f055cfa854d9429c1b7f5789d0fc | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 192 | 126 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-05 | 194 | 126 | 6 | 66dd0469db797c61b094f47426b5212fe52156e9 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-05 | 194 | 126 | 6 | 840220fe357e6e79fb60a530798be2dc12ce8f32 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-05 | 195 | 126 | 6 | 66e5fd9f3208a06d617c5e994822bf57dceae7e2 | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-05 | 195 | 126 | 6 | 9e5cf33b5dd455efa464a63d7116786c0786aefd | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-05 | 197 | 126 | 6 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 197 | 126 | 6 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.16e-05 | 118 | 126 | 5 | 54930a3faa055bda4a707b93d790b2ac5a360211 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.16e-05 | 118 | 126 | 5 | 18f9c1759df9504962612ec741638ed330c33222 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.16e-05 | 118 | 126 | 5 | 97db1193ecc885f63840663ab969468ce21cba74 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.16e-05 | 118 | 126 | 5 | 0c2fe46dd66e0c9cdf8c2eb66874aca79592248a | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.16e-05 | 118 | 126 | 5 | 3f8d11e09a7660af9eca5249ad698d9b638d39dd | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-pDC|ICU-NoSEP / Disease, condition lineage and cell class | 2.20e-05 | 199 | 126 | 6 | a199e67438eeed903d0996605591ec54400fdd66 | |
| ToppCell | Control-Control-Myeloid-pDC|Control / Disease, condition lineage and cell class | 2.20e-05 | 199 | 126 | 6 | 8e9cac53fabe497ffa27fca0627eafe883af2534 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Glia_progenitor_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | 859f98f63797087e7df18be632de153009b6cab1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-05 | 200 | 126 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-05 | 200 | 126 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.08e-05 | 127 | 126 | 5 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.92e-05 | 67 | 126 | 4 | 52f6c244e8d89ccacb79bc5ef3663a5d01fd393c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.92e-05 | 67 | 126 | 4 | e462f9b5dca7c64101a31891f25654c05f2d215d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.98e-05 | 134 | 126 | 5 | 4ef5f395e321cf04e56560be2502a8aa157682f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-05 | 137 | 126 | 5 | 81cdb216e6c81acf9c2072f9d39e1a42612e1258 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 140 | 126 | 5 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.79e-05 | 145 | 126 | 5 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-05 | 148 | 126 | 5 | e7bbb5ddf44b11b8495e83863fbf1fd9f3f24472 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.59e-05 | 149 | 126 | 5 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.80e-05 | 150 | 126 | 5 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | Hippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.02e-05 | 151 | 126 | 5 | 81b2189afd72658f7e2539b856ba79cd49340215 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.47e-05 | 153 | 126 | 5 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.47e-05 | 153 | 126 | 5 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.47e-05 | 153 | 126 | 5 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.49e-05 | 79 | 126 | 4 | 03c5af851b53800eced1c74e9da374c71092bcd4 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.94e-05 | 155 | 126 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.94e-05 | 155 | 126 | 5 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | Striatum-Hematopoietic|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.94e-05 | 155 | 126 | 5 | 12301d823338bf829475905c66c5f08f7159d29f | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 156 | 126 | 5 | cfd7f56f3155db677684827607e9008e975dbe70 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 156 | 126 | 5 | 0d79b4172896574b00faf00e87254f68d76f5512 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.19e-05 | 156 | 126 | 5 | 03f3c5ffb27758fe63797143fcc938f9e8a4e10d | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 156 | 126 | 5 | f09150aacb6121f913648ed3918f9cd4f22c61f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.26e-05 | 81 | 126 | 4 | 1a22222f2b4ab30f7aa31820029c267a0f2190ec | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-05 | 157 | 126 | 5 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-05 | 157 | 126 | 5 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-05 | 157 | 126 | 5 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.69e-05 | 158 | 126 | 5 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-05 | 159 | 126 | 5 | edc193187fedaf5b1d8891231cf862a177eafb64 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 159 | 126 | 5 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.22e-05 | 160 | 126 | 5 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.78e-05 | 162 | 126 | 5 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | E17.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.04e-04 | 164 | 126 | 5 | 4e9de41ea10ce3233c09e144bfc0453c0ae79fd3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 164 | 126 | 5 | 902cfdb8155bb2773aa69826d5b3b810a39c8d34 | |
| ToppCell | E17.5-Endothelial-lymphatic_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.04e-04 | 164 | 126 | 5 | 6f4914b0ac282b4b9f6111930a82515178c1bc80 | |
| Computational | Genes in the cancer module 146. | 1.18e-08 | 102 | 67 | 9 | MODULE_146 | |
| Computational | Genes in the cancer module 27. | GABRG3 TMPRSS15 NPY1R AVPR1A GPR37L1 GPR183 ITGB7 BDKRB2 LEPR P2RY6 P2RY14 ROS1 HCRTR2 | 2.26e-07 | 355 | 67 | 13 | MODULE_27 |
| Computational | Genes in the cancer module 289. | 1.12e-05 | 124 | 67 | 7 | MODULE_289 | |
| Computational | GPCR signaling pathways (immune and neuro). | 1.93e-05 | 90 | 67 | 6 | MODULE_375 | |
| Computational | Genes in the cancer module 134. | 3.34e-05 | 30 | 67 | 4 | MODULE_134 | |
| Computational | Membranal receptors. | GABRG3 NPY1R HTR7 AVPR1A GPR183 ITGB7 BDKRB2 LEPR MEP1A KCNN1 P2RY14 | 3.18e-04 | 517 | 67 | 11 | MODULE_64 |
| Computational | Genes in the cancer module 367. | 7.53e-04 | 29 | 67 | 3 | MODULE_367 | |
| Drug | Loxapine | 6.13e-07 | 4 | 123 | 3 | DB00408 | |
| Drug | Cabergoline | 1.06e-06 | 15 | 123 | 4 | DB00248 | |
| Drug | 7-fluoro-2-oxo-4-(2-(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1-yl)ethyl)-1,2-dihydroquinoline-1-acetamide | 1.53e-06 | 5 | 123 | 3 | ctd:C416534 | |
| Drug | 2-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine | 1.53e-06 | 5 | 123 | 3 | ctd:C045392 | |
| Drug | PGW5 compound | 1.83e-06 | 17 | 123 | 4 | ctd:C000593032 | |
| Drug | Bromocriptine | 2.34e-06 | 18 | 123 | 4 | DB01200 | |
| Drug | trifluperidol | 2.95e-06 | 19 | 123 | 4 | CID000005567 | |
| Drug | SB 200646A | 2.95e-06 | 19 | 123 | 4 | CID000126769 | |
| Drug | 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine | 3.04e-06 | 6 | 123 | 3 | ctd:C434584 | |
| Drug | flupenthixol decanoate | 3.04e-06 | 6 | 123 | 3 | CID006434100 | |
| Drug | Lurasidone Hydrochloride | 5.30e-06 | 7 | 123 | 3 | ctd:D000069056 | |
| Drug | flumezapine | 5.30e-06 | 7 | 123 | 3 | CID000043602 | |
| Drug | 7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine | 5.30e-06 | 7 | 123 | 3 | ctd:C409874 | |
| Drug | 2,3,4,5-Tetrahydro-1H-benzo[d]azepine | 8.45e-06 | 8 | 123 | 3 | CID001400242 | |
| Drug | NNC 756 | 8.45e-06 | 8 | 123 | 3 | CID000132420 | |
| Drug | Olanzapine | 9.40e-06 | 25 | 123 | 4 | DB00334 | |
| Drug | Ziprasidone | 9.40e-06 | 25 | 123 | 4 | DB00246 | |
| Drug | Aripiprazole | 9.40e-06 | 25 | 123 | 4 | DB01238 | |
| Drug | hydroxamates | 9.40e-06 | 25 | 123 | 4 | CID000033630 | |
| Drug | minaprine | 1.09e-05 | 54 | 123 | 5 | CID000004199 | |
| Drug | Clozapine | 1.11e-05 | 26 | 123 | 4 | DB00363 | |
| Drug | tardan | 1.11e-05 | 26 | 123 | 4 | CID000002729 | |
| Drug | Quetiapine | 1.11e-05 | 26 | 123 | 4 | DB01224 | |
| Drug | T15550 | 1.11e-05 | 26 | 123 | 4 | CID000005454 | |
| Drug | cyamemazine | 1.11e-05 | 26 | 123 | 4 | CID000062865 | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; PC3; HT_HG-U133A | 1.11e-05 | 195 | 123 | 8 | 4576_UP | |
| Drug | CHEBI:334542 | 1.26e-05 | 9 | 123 | 3 | CID010884046 | |
| Drug | CHEBI:334375 | 1.26e-05 | 9 | 123 | 3 | CID010476504 | |
| Drug | NIASP | 1.26e-05 | 9 | 123 | 3 | CID006439184 | |
| Drug | Minaprine | 1.26e-05 | 9 | 123 | 3 | DB00805 | |
| Drug | Rilapinum | 1.26e-05 | 9 | 123 | 3 | CID006446980 | |
| Drug | Loxapine | 1.26e-05 | 9 | 123 | 3 | ctd:D008152 | |
| Drug | fluperlapine | 1.29e-05 | 27 | 123 | 4 | CID000049381 | |
| Drug | tenilapine | 1.80e-05 | 10 | 123 | 3 | CID006450478 | |
| Drug | AC1L1G8Z | 1.99e-05 | 30 | 123 | 4 | CID000003581 | |
| Drug | mesulergine | 2.28e-05 | 31 | 123 | 4 | CID000068848 | |
| Drug | NNC 112 | 2.46e-05 | 11 | 123 | 3 | CID000130424 | |
| Drug | LEK 8829 | 2.89e-05 | 2 | 123 | 2 | ctd:C090111 | |
| Drug | Tindal | 2.89e-05 | 2 | 123 | 2 | CID000017676 | |
| Drug | FCE 23884 | 2.89e-05 | 2 | 123 | 2 | ctd:C071320 | |
| Drug | alpha-pyrrolidinovalerophenone | 2.89e-05 | 2 | 123 | 2 | ctd:C542924 | |
| Drug | NSC759871 | 2.89e-05 | 2 | 123 | 2 | CID000441185 | |
| Drug | Acetophenazine | 2.89e-05 | 2 | 123 | 2 | DB01063 | |
| Drug | EEDQ | 2.89e-05 | 2 | 123 | 2 | ctd:C000470 | |
| Drug | thionisoxetine | 2.89e-05 | 2 | 123 | 2 | CID003081925 | |
| Drug | pirenperone | 2.94e-05 | 33 | 123 | 4 | CID000004847 | |
| Drug | mesoridazine | 2.94e-05 | 33 | 123 | 4 | CID000004078 | |
| Drug | ropinirole | 2.94e-05 | 33 | 123 | 4 | CID000005095 | |
| Drug | octoclothepin | 3.27e-05 | 12 | 123 | 3 | CID000001238 | |
| Drug | Chlorprothixene | 3.27e-05 | 12 | 123 | 3 | DB01239 | |
| Drug | S 14506 | 3.27e-05 | 12 | 123 | 3 | CID000131905 | |
| Drug | AC1L1CXF | 4.18e-05 | 36 | 123 | 4 | CID000002104 | |
| Drug | molindone | 4.18e-05 | 36 | 123 | 4 | CID000023897 | |
| Drug | iloperidone | 4.18e-05 | 36 | 123 | 4 | CID000071360 | |
| Drug | Spiperone | 4.23e-05 | 13 | 123 | 3 | ctd:D013134 | |
| Drug | Sordinol | 4.23e-05 | 13 | 123 | 3 | CID000012453 | |
| Drug | clonidine | 4.93e-05 | 240 | 123 | 8 | CID000002803 | |
| Drug | propiomazine | 5.36e-05 | 14 | 123 | 3 | CID000004940 | |
| Drug | Lisuride | 5.36e-05 | 14 | 123 | 3 | DB00589 | |
| Drug | Promazine | 5.36e-05 | 14 | 123 | 3 | DB00420 | |
| Drug | Pramipexole | 5.36e-05 | 14 | 123 | 3 | DB00413 | |
| Drug | Ropinirole | 5.36e-05 | 14 | 123 | 3 | DB00268 | |
| Drug | Risperidone | 5.36e-05 | 14 | 123 | 3 | DB00734 | |
| Drug | Propiomazine | 5.36e-05 | 14 | 123 | 3 | DB00777 | |
| Drug | Paliperidone Palmitate | 5.36e-05 | 14 | 123 | 3 | ctd:D000068882 | |
| Drug | AC1L1H5B | 6.14e-05 | 77 | 123 | 5 | CID000003981 | |
| Drug | NSC95090 | 6.38e-05 | 40 | 123 | 4 | CID000003251 | |
| Drug | Gabrene | 6.38e-05 | 40 | 123 | 4 | CID005361323 | |
| Drug | thiethylperazine | 6.68e-05 | 15 | 123 | 3 | CID000005440 | |
| Drug | Apomorphine | 6.68e-05 | 15 | 123 | 3 | DB00714 | |
| Drug | OPC-4392 | 6.68e-05 | 15 | 123 | 3 | CID000163839 | |
| Drug | A 86929 | 6.68e-05 | 15 | 123 | 3 | ctd:C095427 | |
| Drug | AC1L2AAS | 6.68e-05 | 15 | 123 | 3 | CID000068714 | |
| Drug | elymoclavin | 6.68e-05 | 15 | 123 | 3 | CID000011051 | |
| Drug | mitragynine | 6.68e-05 | 15 | 123 | 3 | ctd:C001801 | |
| Drug | Saphris | 7.04e-05 | 41 | 123 | 4 | CID000163091 | |
| Drug | spiroxatrine | 7.74e-05 | 42 | 123 | 4 | CID000005268 | |
| Drug | Fluphenazine | 8.18e-05 | 16 | 123 | 3 | ctd:D005476 | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 8.19e-05 | 191 | 123 | 7 | 3975_DN | |
| Drug | Thiothixene | 8.65e-05 | 3 | 123 | 2 | DB01623 | |
| Drug | alpha-methyl-m-tyrosine | 8.65e-05 | 3 | 123 | 2 | CID000002110 | |
| Drug | Thiethylperazine | 8.65e-05 | 3 | 123 | 2 | DB00372 | |
| Drug | 6-methoxymianserin | 8.65e-05 | 3 | 123 | 2 | ctd:C461657 | |
| Drug | CHEBI:334538 | 8.65e-05 | 3 | 123 | 2 | CID011068912 | |
| Drug | CHEBI:334543 | 8.65e-05 | 3 | 123 | 2 | CID011057969 | |
| Drug | Perphenazine | 8.65e-05 | 3 | 123 | 2 | DB00850 | |
| Drug | gamma-mangostin | 8.65e-05 | 3 | 123 | 2 | ctd:C102777 | |
| Drug | Fluphenazine | 8.65e-05 | 3 | 123 | 2 | DB00623 | |
| Drug | AC1LR3WA | 8.65e-05 | 3 | 123 | 2 | CID001361946 | |
| Drug | CHEBI:334449 | 8.65e-05 | 3 | 123 | 2 | CID010895106 | |
| Drug | carphenazine | 8.65e-05 | 3 | 123 | 2 | CID000018104 | |
| Drug | Carphenazine | 8.65e-05 | 3 | 123 | 2 | DB01038 | |
| Drug | CHEBI:334157 | 8.65e-05 | 3 | 123 | 2 | CID011133602 | |
| Drug | CHEBI:334539 | 8.65e-05 | 3 | 123 | 2 | CID011036640 | |
| Drug | CHEBI:334156 | 8.65e-05 | 3 | 123 | 2 | CID011036641 | |
| Drug | U-62066 [87151-85-7]; Up 200; 1uM; MCF7; HT_HG-U133A | 8.75e-05 | 193 | 123 | 7 | 3901_UP | |
| Drug | prazosin | 8.75e-05 | 193 | 123 | 7 | CID000004893 | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.75e-05 | 193 | 123 | 7 | 4154_DN | |
| Drug | AC1L1JJR | 9.32e-05 | 44 | 123 | 4 | CID000005072 | |
| Drug | Paliperidone | 9.90e-05 | 17 | 123 | 3 | DB01267 | |
| Disease | Amphetamine-Related Disorders | 1.41e-05 | 75 | 120 | 5 | C0236733 | |
| Disease | Amphetamine Abuse | 1.41e-05 | 75 | 120 | 5 | C0236807 | |
| Disease | Amphetamine Addiction | 1.41e-05 | 75 | 120 | 5 | C0236804 | |
| Disease | granulosa cell tumor | 4.91e-05 | 3 | 120 | 2 | C0018206 | |
| Disease | anxiety disorder (implicated_via_orthology) | 9.55e-05 | 22 | 120 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 1.40e-04 | 121 | 120 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | Bipolar Disorder | 1.50e-04 | 477 | 120 | 9 | C0005586 | |
| Disease | Granulosa Cell Cancer | 1.63e-04 | 5 | 120 | 2 | C1567257 | |
| Disease | heroin dependence (biomarker_via_orthology) | 1.63e-04 | 5 | 120 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | Depressive disorder | 1.86e-04 | 289 | 120 | 7 | C0011581 | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 2.43e-04 | 6 | 120 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | Hyperkinesia | 2.98e-04 | 32 | 120 | 3 | C3887506 | |
| Disease | Hyperkinesia, Generalized | 2.98e-04 | 32 | 120 | 3 | C0751217 | |
| Disease | epilepsy (implicated_via_orthology) | 5.53e-04 | 163 | 120 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | pancreatitis (implicated_via_orthology) | 5.80e-04 | 9 | 120 | 2 | DOID:4989 (implicated_via_orthology) | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 5.80e-04 | 9 | 120 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | Recurrent depression | 5.80e-04 | 9 | 120 | 2 | C0221480 | |
| Disease | cytokine measurement | 6.11e-04 | 461 | 120 | 8 | EFO_0004873 | |
| Disease | Unipolar Depression | 6.84e-04 | 259 | 120 | 6 | C0041696 | |
| Disease | Alopecia Areata | 7.23e-04 | 10 | 120 | 2 | C0002171 | |
| Disease | Anxiety States, Neurotic | 7.69e-04 | 44 | 120 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 7.69e-04 | 44 | 120 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 7.69e-04 | 44 | 120 | 3 | C0003469 | |
| Disease | Weight Gain | 8.13e-04 | 102 | 120 | 4 | C0043094 | |
| Disease | Alcoholic Intoxication, Chronic | 8.17e-04 | 268 | 120 | 6 | C0001973 | |
| Disease | Pain, Migratory | 1.05e-03 | 49 | 120 | 3 | C0751407 | |
| Disease | Suffering, Physical | 1.05e-03 | 49 | 120 | 3 | C0751408 | |
| Disease | Pain, Crushing | 1.05e-03 | 49 | 120 | 3 | C0458259 | |
| Disease | Pain, Splitting | 1.05e-03 | 49 | 120 | 3 | C0458257 | |
| Disease | Pain | 1.05e-03 | 49 | 120 | 3 | C0030193 | |
| Disease | Radiating pain | 1.05e-03 | 49 | 120 | 3 | C0234254 | |
| Disease | Pain, Burning | 1.05e-03 | 49 | 120 | 3 | C0234230 | |
| Disease | Ache | 1.05e-03 | 49 | 120 | 3 | C0234238 | |
| Disease | Hypotension | 1.32e-03 | 53 | 120 | 3 | C0020649 | |
| Disease | lung disease severity measurement | 1.40e-03 | 118 | 120 | 4 | EFO_0007744 | |
| Disease | trimethylamine-N-oxide measurement | 1.45e-03 | 14 | 120 | 2 | EFO_0010541 | |
| Disease | Waxy flexibility | 1.66e-03 | 15 | 120 | 2 | C0233612 | |
| Disease | Dyskinesia, Medication-Induced | 1.66e-03 | 15 | 120 | 2 | C0751088 | |
| Disease | Catalepsy | 1.66e-03 | 15 | 120 | 2 | C0007370 | |
| Disease | Dyskinesia, Drug-Induced | 1.66e-03 | 15 | 120 | 2 | C0013386 | |
| Disease | Neuralgia, Supraorbital | 1.90e-03 | 16 | 120 | 2 | C0038870 | |
| Disease | Neuralgia | 1.90e-03 | 16 | 120 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 1.90e-03 | 16 | 120 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.90e-03 | 16 | 120 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.90e-03 | 16 | 120 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.90e-03 | 16 | 120 | 2 | C0423711 | |
| Disease | Seasonal Affective Disorder | 1.90e-03 | 16 | 120 | 2 | C0085159 | |
| Disease | Paroxysmal Nerve Pain | 1.90e-03 | 16 | 120 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.90e-03 | 16 | 120 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.90e-03 | 16 | 120 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.90e-03 | 16 | 120 | 2 | C0042656 | |
| Disease | attention function measurement | 3.18e-03 | 148 | 120 | 4 | EFO_0007636 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 3.27e-03 | 21 | 120 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | depressive disorder (implicated_via_orthology) | 3.59e-03 | 22 | 120 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | Mental Depression | 3.88e-03 | 254 | 120 | 5 | C0011570 | |
| Disease | Carcinoma of lung | 3.92e-03 | 23 | 120 | 2 | C0684249 | |
| Disease | Etat Marbre | 3.92e-03 | 23 | 120 | 2 | C0266487 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVVVVVVAFALCWTP | 256 | P49682 | |
| STTACPVAFILLVWN | 21 | P0DMU3 | |
| ICWLPFQISTFLDTL | 281 | P30411 | |
| PCGIITSVLAWVTAI | 146 | O00421 | |
| ANWTGTCTLVFLTPK | 351 | Q9N2K0 | |
| ANWTGTCTLVFLTPK | 351 | Q9N2J8 | |
| WFLVPISSVICNDIT | 241 | Q92903 | |
| TLFTEWSVPETCFVL | 46 | Q5SY80 | |
| VWFLGTINCITVALV | 1041 | Q4VNC1 | |
| LCPVWISLDVLFSTA | 126 | P28335 | |
| VVACTSAFLLWDPTK | 106 | P30043 | |
| VAWTLSVLISFIPVQ | 146 | P21728 | |
| QTLSNCVEYLVPWVT | 486 | A1A5B4 | |
| VSSIIIVCGTLFVFW | 781 | P98194 | |
| DLCTVQIPTTWRTIF | 241 | Q9H2T7 | |
| VSWTCLQTIRFSPDI | 386 | Q6P2E9 | |
| PLFSVLLWIAVAICT | 2261 | Q14571 | |
| CSPFLVTLITLWVYV | 541 | O15438 | |
| FVSILLKCFDSPWTT | 156 | Q8IWT6 | |
| TVTTFVPGALTWLLC | 16 | A0A1B0GVX0 | |
| IVCPALWEAVLYTLT | 311 | O94822 | |
| CVYLWAALPVVISIV | 506 | Q5T3U5 | |
| CASLVAAPWVIAILN | 141 | Q8NHA8 | |
| IFVLNKCDLVPTWAT | 251 | Q13823 | |
| CVFLLATQPLVWVSL | 291 | Q9GZN0 | |
| WTVPFLSSLACLILA | 791 | Q6DN12 | |
| PCVLTLNQDGTVWVT | 341 | O75648 | |
| VLTIIQTSCGVIWPC | 211 | Q9NYP7 | |
| TLCDFWEPNIAIVTI | 411 | Q6ZRQ5 | |
| CPGTVLLVFSISSWI | 281 | Q92952 | |
| PSETSVVCQWIIRVN | 246 | P98073 | |
| FAVCWCPINVLTVLV | 246 | Q13585 | |
| STCTIPQALAIFWFR | 76 | Q8NGK2 | |
| ISPQVCVALVVASWI | 136 | Q8NGD2 | |
| TCWEALVSPVVQNIT | 1041 | Q14999 | |
| LLSVAACWFLPSIIA | 46 | Q9H295 | |
| PSIIAAAASWIITCV | 56 | Q9H295 | |
| FTWTNLLVVVVELCG | 1496 | Q9P265 | |
| VCAGVWVLATLFSVP | 151 | Q8TDT2 | |
| AYPLNSSCVIVSWIL | 746 | P48357 | |
| SCLLSIVNPEWAVAI | 1676 | P50748 | |
| TPQTYLIIWVITNCV | 486 | Q9HCC8 | |
| CPSFLVTGQWVVVTE | 116 | O60774 | |
| ALTWTCLLVRIVFPS | 116 | Q92616 | |
| AISTERCVCVLFPIW | 166 | P35410 | |
| TVTFWVSLQATHCLP | 436 | P26010 | |
| VVICTLWLIFAAPTV | 716 | Q5T6X5 | |
| VCFLSTWLPFVLLQV | 246 | Q9UJ42 | |
| ILLLAWPFAAISTVC | 76 | Q7L5N7 | |
| LSIVVAFAVCWLPLT | 266 | P25929 | |
| IVVTFGACWLPRISS | 266 | Q99463 | |
| ATIRIWSVPNASCVQ | 286 | Q9UMS4 | |
| TCLPATLVVDITETW | 106 | O43614 | |
| CVWIVVTSPDLLVTF | 616 | O60494 | |
| EVVPSLACEWSQLTL | 386 | P51587 | |
| FQIQSFDIVCSPVWT | 2701 | Q99715 | |
| QTYIPCILTVVLSWV | 276 | Q8N1C3 | |
| YIPCILTVVLSWVSF | 261 | Q99928 | |
| VVCIALVTNAWVFLL | 241 | Q9NZD1 | |
| PILFTVTCQLVTWRV | 321 | O60883 | |
| PWVVRRAVTVAFCTL | 151 | Q5TA50 | |
| VLTAAVPRFCSWLVE | 501 | Q5TEA3 | |
| AIITSNPWICVSGEL | 951 | Q6ZUT9 | |
| NVTLQCVFWVEDPTL | 341 | Q9Y653 | |
| CWEALVSPLVQNITS | 1371 | Q8IWT3 | |
| ISIVWVLSFTISCPL | 156 | P14416 | |
| TLCSVLLPVFITFWC | 26 | P52429 | |
| LLPVFITFWCSLQRS | 31 | P52429 | |
| TFLLCWTPISVLNTT | 321 | Q99680 | |
| VSCVSLWPGIVQTEL | 186 | Q96LJ7 | |
| IAVLTTICCFWPTGI | 226 | Q99946 | |
| AIYWCTEVIPLAVTS | 46 | Q86YT5 | |
| LSILWVLLFTPCSFV | 201 | O14828 | |
| VIVVSVFIACWSPLF | 246 | Q99500 | |
| WFSLPVTATAENCIL | 1406 | Q6ZTR5 | |
| FVPFVCWIVCTVLRQ | 386 | P59044 | |
| TWCTAPARAIQVTVS | 81 | Q86X29 | |
| VWLAVTTQCLPTAIF | 151 | Q15077 | |
| SWFLVVSRPVSNACL | 446 | Q9HB75 | |
| LTCTTTLPNALCIFW | 81 | Q8NH56 | |
| IFPLLSLACADTWVN | 181 | P0C626 | |
| IAPWIALACTNTQAV | 181 | Q8NGZ6 | |
| LVVTAILIQTPWSFT | 296 | P03905 | |
| CTSTLPNTLFILWFN | 76 | Q8NH53 | |
| STIKQLLAFCWSVPA | 146 | Q9P1P4 | |
| LWHTVAIATCVPNEV | 401 | Q17RP2 | |
| NICETIVWKAFSPTT | 186 | Q9H9S3 | |
| WRVFVIVCALPCTVS | 276 | Q7L1I2 | |
| VSVSGICISVSWILP | 146 | Q96RI8 | |
| VVLSIFSVIVVWSEC | 391 | Q68DH5 | |
| IVSPQWVITAAHCIA | 81 | Q7RTZ1 | |
| VCIFVWILVFAQTLP | 151 | P32249 | |
| CPTGVWTVRNFSQVL | 431 | Q16819 | |
| LCTLPTANWKFATVI | 611 | Q5VXU9 | |
| AAVVAWCTLIPLSCF | 321 | Q86UG4 | |
| LVCLSFAALTPVWVL | 256 | Q96GZ6 | |
| PWQLNVFVCRVSAVL | 86 | Q15391 | |
| LRLLCPQAFSTTVWQ | 296 | Q9H6W3 | |
| SVLIPVACVWIVSAF | 266 | Q6PIS1 | |
| LKSASNPRVCTFVWI | 391 | Q14849 | |
| NPRVCTFVWILNTDL | 396 | Q14849 | |
| TSCSCIPLWVERTFL | 356 | P34969 | |
| TLVSCALPLWKVTAF | 21 | O95484 | |
| IIVTIIITFFLCWCP | 261 | Q99788 | |
| FIVICSILGTQAWIT | 21 | Q8NCR9 | |
| CVVVSRDWLSLVPAF | 21 | Q8TAT8 | |
| CFTTPASLNGLEIIW | 401 | Q9BXU1 | |
| VITPLWIITAAHCVY | 246 | P57727 | |
| TTLSPWSFLIILCFI | 226 | Q9BZM4 | |
| ISFVDSFPLSIWICQ | 716 | A0JNW5 | |
| LISPNSVFSQWRVVC | 276 | P17643 | |
| NICETIVWKAFSPTT | 186 | P61619 | |
| WFSLFITVTILVNCV | 131 | Q9Y5Y9 | |
| PIIFGFTIDSTCILW | 631 | Q6ZQN7 | |
| IWDLQSCQATRTVPV | 221 | Q12788 | |
| ITSWVVIFILPINSA | 661 | Q9HBX9 | |
| VLVCNAATFALPWSL | 206 | Q9NZC7 | |
| TVCFILSLWSIAESP | 996 | Q96SB8 | |
| LVNFATLGCLWISVV | 11 | P08922 | |
| QTSISQWVPVCSRLI | 11 | Q9NVA1 | |
| IAAAWVLSFVLSTPQ | 171 | P37288 | |
| WLAVVVVPLAVSVAC | 41 | P0C7T8 | |
| VTQQCVIAEIWFPVA | 316 | Q9HBG4 | |
| VAILALWFCISVPLT | 471 | Q99805 | |
| IYVWCTVLTLEPNSQ | 2821 | Q7Z7G8 | |
| VLVPWNRALCSQLFS | 156 | Q9P272 | |
| CIPKEQLSTSFQWVT | 491 | Q9NYY3 | |
| LGFAVSISLWICVQI | 26 | Q9NV66 | |
| WTPIALTVFLVAVAT | 171 | Q6ZXV5 | |
| VTFILPVCPTFTIWN | 681 | Q9UJV3 | |
| LGFAVSISLWICVQI | 26 | Q6NUM6 | |
| LQCLIQWFETAPSRT | 31 | Q9BWF2 | |
| WVILAISVPISSCSV | 471 | Q6UXF1 | |
| CNVKASESPSIFWVL | 501 | Q9NR99 | |
| VASIVWSVLFLPICT | 26 | Q9BTX1 | |
| WSVLFLPICTTVFII | 31 | Q9BTX1 |